TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10947095
log Bayes Factor = 89.9123
Chromosome 6   position 30,757,575  (GRCh37) Explore rs10947095 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
T36-T50 Poisoning by drugs, medicaments and biological substances
1.000 0.000 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.000 1.000
E16.2 Hypoglycaemia, unspecified
0.000 0.001 0.999
E16 Other disorders of pancreatic internal secretion
0.000 0.001 0.999
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.999 0.001 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.998 0.002 0.000
T39.1 4-Aminophenol derivatives
0.993 0.007 0.000
L40.0 Psoriasis vulgaris
0.992 0.008 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.009 0.991
E04 Other non-toxic goitre
0.000 0.011 0.989
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.988 0.012 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.013 0.987
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.986 0.014 0.000
E10.1 With ketoacidosis
0.000 0.023 0.977
T43.2 Other and unspecified antidepressants
0.972 0.028 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.970 0.030 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.967 0.033 0.000
E14 Unspecified diabetes mellitus
0.000 0.041 0.959
E10.5 With peripheral circulatory complications
0.000 0.051 0.949
E10.4 With neurological complications
0.000 0.051 0.949
E14.3 With ophthalmic complications
0.000 0.052 0.948
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.945 0.055 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.943 0.057 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.943 0.057 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.937 0.063 0.000
L40.1 Generalised pustular psoriasis
0.920 0.080 0.000
L40.8 Other psoriasis
0.900 0.100 0.000
E10.8 With unspecified complications
0.000 0.105 0.895
T43.5 Other and unspecified antipsychotics and neuroleptics
0.886 0.114 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.880 0.120 0.000
E10.6 With other specified complications
0.000 0.122 0.878
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.876 0.124 0.000
E10.0 With coma
0.000 0.131 0.869
E50-E64 Other nutritional deficiencies
0.000 0.132 0.868
E05.8 Other thyrotoxicosis
0.000 0.148 0.852
T43.0 Tricyclic and tetracyclic antidepressants
0.850 0.150 0.000
T43.6 Psychostimulants with abuse potential
0.835 0.165 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.829 0.171 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.183 0.817
T42.4 Benzodiazepines
0.813 0.187 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.800 0.200 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.791 0.209 0.000
T42.1 Iminostilbenes
0.781 0.219 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.778 0.222 0.000
E14.6 With other specified complications
0.000 0.226 0.774
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.770 0.230 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.770 0.230 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.769 0.231 0.000
T39.0 Salicylates
0.769 0.231 0.000
T45.0 Antiallergic and antiemetic drugs
0.768 0.232 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.766 0.234 0.000
E10.2 With renal complications
0.000 0.234 0.766
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.759 0.241 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.745 0.255 0.000
E07 Other disorders of thyroid
0.000 0.262 0.738
T46 Poisoning by agents primarily affecting the cardiovascular system
0.735 0.265 0.000
E53 Deficiency of other B group vitamins
0.000 0.268 0.732
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.271 0.729
T36 Poisoning by systemic antibiotics
0.727 0.273 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.726 0.274 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.719 0.281 0.000
E55 Vitamin D deficiency
0.000 0.281 0.719
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
L40.4 Guttate psoriasis
0.717 0.283 0.000
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.717 0.283 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.717 0.283 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.717 0.283 0.000
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E15 Nondiabetic hypoglycaemic coma
0.000 0.283 0.717
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.283 0.717
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.283 0.717
E16.4 Abnormal secretion of gastrin
0.000 0.283 0.717
E16.3 Increased secretion of glucagon
0.000 0.283 0.717
T43.9 Psychotropic drug, unspecified
0.717 0.283 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.717 0.283 0.000
T39.4 Antirheumatics, not elsewhere classified
0.715 0.284 0.000
T39.2 Pyrazolone derivatives
0.715 0.284 0.000
E04.8 Other specified non-toxic goitre
0.000 0.291 0.709
T42.5 Mixed antiepileptics, not elsewhere classified
0.708 0.291 0.000
T42.3 Barbiturates
0.708 0.291 0.000
T42.2 Succinimides and oxazolidinediones
0.708 0.291 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.707 0.293 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.707 0.293 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.707 0.293 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.707 0.293 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.707 0.293 0.000
T44.0 Anticholinesterase agents
0.707 0.293 0.000
T47.0 Histamine H(2)-receptor antagonists
0.695 0.304 0.000
T50.8 Diagnostic agents
0.693 0.307 0.000
T50.7 Analeptics and opioid receptor antagonists
0.693 0.307 0.000
T50.5 Appetite depressants
0.693 0.307 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.693 0.307 0.000
T50.1 Loop [high-ceiling] diuretics
0.693 0.307 0.000
T50.0 Mineralocorticoids and their antagonists
0.693 0.307 0.000
E14.7 With multiple complications
0.000 0.312 0.687
E14.2 Withrenal complications
0.000 0.312 0.687
E14.0 With coma
0.000 0.312 0.687
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.683 0.317 0.000
H36.0 Diabetic retinopathy
0.000 0.321 0.679
E06 Thyroiditis
0.000 0.324 0.676
E14.1 With ketoacidosis
0.000 0.328 0.672
E04.0 Non-toxic diffuse goitre
0.000 0.340 0.660
E14.5 With peripheral circulatory complications
0.000 0.341 0.659
E51 Thiamine deficiency
0.000 0.341 0.659
E58 Dietary calcium deficiency
0.000 0.342 0.658
T48.5 Anti-common-cold drugs
0.656 0.343 0.000
E16.1 Other hypoglycaemia
0.000 0.346 0.654
E07.9 Disorder of thyroid, unspecified
0.000 0.355 0.645
E14.4 With neurological complications
0.000 0.358 0.642
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.364 0.636
T50.4 Drugs affecting uric acid metabolism
0.634 0.365 0.000
E14.8 With unspecified complications
0.000 0.368 0.631
T45.9 Primarily systemic and haematological agent, unspecified
0.631 0.369 0.000
T45.8 Other primarily systemic and haematological agents
0.631 0.369 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.631 0.369 0.000
T45.6 Fibrinolysis-affecting drugs
0.631 0.369 0.000
T45.4 Iron and its compounds
0.631 0.369 0.000
T45.3 Enzymes, not elsewhere classified
0.631 0.369 0.000
T47.4 Other laxatives
0.626 0.374 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.377 0.623
E63 Other nutritional deficiencies
0.000 0.377 0.623
E56 Other vitamin deficiencies
0.000 0.377 0.623
E50 Vitamin A deficiency
0.000 0.377 0.623
E60 Dietary zinc deficiency
0.000 0.377 0.623
E59 Dietary selenium deficiency
0.000 0.377 0.623
E54 Ascorbic acid deficiency
0.000 0.377 0.623
E52 Niacin deficiency [pellagra]
0.000 0.377 0.623
E55.9 Vitamin D deficiency, unspecified
0.000 0.389 0.611
E53.9 Vitamin B deficiency, unspecified
0.000 0.393 0.607
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.604 0.396 0.000
T46.1 Calcium-channel blockers
0.597 0.403 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.594 0.405 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.594 0.405 0.000
T47.7 Emetics
0.594 0.405 0.000
T47.6 Antidiarrhoeal drugs
0.594 0.405 0.000
T47.5 Digestants
0.594 0.405 0.000
T47.3 Saline and osmotic laxatives
0.594 0.405 0.000
T47.2 Stimulant laxatives
0.594 0.405 0.000
T45.5 Anticoagulants
0.586 0.414 0.000
T42.0 Hydantoin derivatives
0.585 0.415 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.580 0.420 0.000
E03.1 Congenital hypothyroidism without goitre
0.000 0.421 0.579
E04.2 Non-toxic multinodular goitre
0.000 0.425 0.575
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.573 0.426 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.573 0.426 0.000
T48.4 Expectorants
0.573 0.426 0.000
T48.3 Antitussives
0.573 0.426 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.573 0.426 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.573 0.426 0.000
T48.0 Oxytocic drugs
0.573 0.426 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.431 0.569
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.564 0.436 0.000
E06.3 Autoimmune thyroiditis
0.000 0.438 0.562
T38.1 Thyroid hormones and substitutes
0.549 0.451 0.000
T36.0 Penicillins
0.531 0.468 0.000
E07.1 Dyshormogenetic goitre
0.000 0.471 0.529
E07.0 Hypersecretion of calcitonin
0.000 0.471 0.529
E40-E46 Malnutrition
0.000 0.471 0.528
E13 Other specified diabetes mellitus
0.000 0.472 0.528
T46.4 Angiotensin-converting-enzyme inhibitors
0.528 0.472 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.527 0.473 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.527 0.473 0.000
T46.7 Peripheral vasodilators
0.527 0.473 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.527 0.473 0.000
E53.1 Pyridoxine deficiency
0.000 0.475 0.525
E53.0 Riboflavin deficiency
0.000 0.475 0.525
T36.9 Systemic antibiotic, unspecified
0.521 0.478 0.000
T36.8 Other systemic antibiotics
0.521 0.478 0.000
T36.7 Antifungal antibiotics, systemically used
0.521 0.478 0.000
T36.6 Rifamycins
0.521 0.478 0.000
T36.5 Aminoglycosides
0.521 0.478 0.000
T36.4 Tetracyclines
0.521 0.478 0.000
T36.3 Macrolides
0.521 0.478 0.000
T36.2 Chloramphenicol group
0.521 0.478 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.521 0.478 0.000
T45.2 Vitamins, not elsewhere classified
0.519 0.481 0.000
K90 Intestinal malabsorption
0.000 0.481 0.519
T38.9 Other and unspecified hormone antagonists
0.516 0.484 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.516 0.484 0.000
T38.7 Androgens and anabolic congeners
0.516 0.484 0.000
T38.5 Other oestrogens and progestogens
0.516 0.484 0.000
T38.4 Oral contraceptives
0.516 0.484 0.000
T38.2 Antithyroid drugs
0.516 0.484 0.000
T38.0 Glucocorticoids and synthetic analogues
0.516 0.484 0.000
E55.0 Rickets, active
0.000 0.485 0.515
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.514 0.486 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.514 0.486 0.000
T37.5 Antiviral drugs
0.514 0.486 0.000
T37.4 Anthelminthics
0.514 0.486 0.000
T37.3 Other antiprotozoal drugs
0.514 0.486 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.514 0.486 0.000
T37.1 Antimycobacterial drugs
0.514 0.486 0.000
T37.0 Sulphonamides
0.514 0.486 0.000
T41.5 Therapeutic gases
0.514 0.486 0.000
T41.4 Anaesthetic, unspecified
0.514 0.486 0.000
T41.3 Local anaesthetics
0.514 0.486 0.000
T41.2 Other and unspecified general anaesthetics
0.514 0.486 0.000
T41.1 Intravenous anaesthetics
0.514 0.486 0.000
T41.0 Inhaled anaesthetics
0.514 0.486 0.000
T49.9 Topical agent, unspecified
0.514 0.486 0.000
T49.8 Other topical agents
0.514 0.486 0.000
T49.7 Dental drugs, topically applied
0.514 0.486 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.514 0.486 0.000
T49.5 Ophthalmological drugs and preparations
0.514 0.486 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.514 0.486 0.000
T49.3 Emollients, demulcents and protectants
0.514 0.486 0.000
T49.2 Local astringents and local detergents
0.514 0.486 0.000
T49.1 Antipruritics
0.514 0.486 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.514 0.486 0.000
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E51.2 Wernicke's encephalopathy
0.000 0.491 0.508
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.501 0.499 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.498 0.502 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.495 0.505 0.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.505 0.495
T46.3 Coronary vasodilators, not elsewhere classified
0.494 0.506 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.511 0.489
E61 Deficiency of other nutrient elements
0.000 0.512 0.487
E06.4 Drug-induced thyroiditis
0.000 0.515 0.485
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.515 0.485
E06.0 Acute thyroiditis
0.000 0.515 0.485
E06.5 Other chronic thyroiditis
0.000 0.527 0.473
E51.9 Thiamine deficiency, unspecified
0.000 0.528 0.472
E51.8 Other manifestations of thiamine deficiency
0.000 0.528 0.472
E51.1 Beriberi
0.000 0.528 0.472
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.537 0.463
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.544 0.456
M07.39 Other psoriatic arthropathies (Site unspecified)
0.455 0.545 0.000
E03.8 Other specified hypothyroidism
0.001 0.546 0.454
M07.3 Other psoriatic arthropathies
0.450 0.550 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
0.449 0.551 0.000
E50.9 Vitamin A deficiency, unspecified
0.000 0.553 0.446
E50.8 Other manifestations of vitamin A deficiency
0.000 0.553 0.446
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.553 0.446
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.553 0.446
E50.5 Vitamin A deficiency with night blindness
0.000 0.553 0.446
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.553 0.446
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.553 0.446
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.553 0.446
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.553 0.446
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.553 0.446
E56.9 Vitamin deficiency, unspecified
0.000 0.553 0.446
E56.8 Deficiency of other vitamins
0.000 0.553 0.446
E56.1 Deficiency of vitamin K
0.000 0.553 0.446
E56.0 Deficiency of vitamin E
0.000 0.553 0.446
E63.9 Nutritional deficiency, unspecified
0.000 0.553 0.446
E63.8 Other specified nutritional deficiencies
0.000 0.553 0.446
E63.1 Imbalance of constituents of food intake
0.000 0.553 0.446
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.553 0.446
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.553 0.446
E64.8 Sequelae of other nutritional deficiencies
0.000 0.553 0.446
E64.3 Sequelae of rickets
0.000 0.553 0.446
E64.2 Sequelae of vitamin C deficiency
0.000 0.553 0.446
E64.1 Sequelae of vitamin A deficiency
0.000 0.553 0.446
E64.0 Sequelae of protein-energy malnutrition
0.000 0.553 0.446
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.564 0.436
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.573 0.427
K90.9 Intestinal malabsorption, unspecified
0.000 0.576 0.424
E06.1 Subacute thyroiditis
0.000 0.577 0.423
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.593 0.407
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.596 0.404
E06.9 Thyroiditis, unspecified
0.000 0.600 0.400
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.605 0.395
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.391 0.608 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.621 0.379
E45 Retarded development following protein-energy malnutrition
0.000 0.621 0.379
E43 Unspecified severe protein-energy malnutrition
0.000 0.621 0.379
E42 Marasmic kwashiorkor
0.000 0.621 0.379
E41 Nutritional marasmus
0.000 0.621 0.379
E40 Kwashiorkor
0.000 0.621 0.379
E13.8 With unspecified complications
0.000 0.621 0.379
E13.7 With multiple complications
0.000 0.621 0.379
E13.6 With other specified complications
0.000 0.621 0.379
E13.5 With peripheral circulatory complications
0.000 0.621 0.379
E13.4 With neurological complications
0.000 0.621 0.379
E13.2 With renal complications
0.000 0.621 0.379
E13.1 With ketoacidosis
0.000 0.621 0.379
E13.0 With coma
0.000 0.621 0.379
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.627 0.373
K90.3 Pancreatic steatorrhoea
0.000 0.628 0.372
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.628 0.372
K90.1 Tropical sprue
0.000 0.628 0.372
E13.3 With ophthalmic complications
0.000 0.637 0.363
K90.8 Other intestinal malabsorption
0.000 0.637 0.363
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.637 0.363
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.641 0.359
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.647 0.353
H36 Retinal disorders in diseases classified elsewhere
0.000 0.648 0.352
E61.9 Deficiency of nutrient element, unspecified
0.000 0.650 0.350
E61.8 Deficiency of other specified nutrient elements
0.000 0.650 0.350
E61.7 Deficiency of multiple nutrient elements
0.000 0.650 0.350
E61.6 Vanadium deficiency
0.000 0.650 0.350
E61.5 Molybdenum deficiency
0.000 0.650 0.350
E61.4 Chromium deficiency
0.000 0.650 0.350
E61.3 Manganese deficiency
0.000 0.650 0.350
E61.0 Copper deficiency
0.000 0.650 0.350
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.349 0.650 0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.344 0.656 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.341 0.659 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.339 0.660 0.000
M07.38 Other psoriatic arthropathies (Other)
0.323 0.677 0.000
M07.33 Other psoriatic arthropathies (Forearm)
0.323 0.677 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.323 0.677 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.323 0.677 0.000
E61.2 Magnesium deficiency
0.000 0.681 0.319
E07.8 Other specified disorders of thyroid
0.001 0.688 0.312
M07.34 Other psoriatic arthropathies (Hand)
0.306 0.694 0.000
E14.9 Without complications
0.000 0.701 0.299
E65-E68 Obesity and other hyperalimentation
0.000 0.710 0.289
E44.1 Mild protein-energy malnutrition
0.000 0.728 0.272
E44.0 Moderate protein-energy malnutrition
0.000 0.728 0.272
E61.1 Iron deficiency
0.000 0.736 0.264
E04.1 Non-toxic single thyroid nodule
0.000 0.739 0.261
T40.5 Cocaine
0.257 0.743 0.000
H36.8 Other retinal disorders in diseases classified elsewhere
0.000 0.747 0.253
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.245 0.755 0.000
T40.8 Lysergide [LSD]
0.245 0.755 0.000
T40.7 Cannabis (derivatives)
0.245 0.755 0.000
T40.3 Methadone
0.245 0.755 0.000
T40.1 Heroin
0.245 0.755 0.000
T40.0 Opium
0.245 0.755 0.000
T40.6 Other and unspecified narcotics
0.224 0.775 0.000
L40-L45 Papulosquamous disorders
0.223 0.777 0.001
E13.9 Without complications
0.000 0.777 0.223
E67 Other hyperalimentation
0.000 0.792 0.207
E68 Sequelae of hyperalimentation
0.000 0.792 0.207
M06 Other rheumatoid arthritis
0.001 0.793 0.206
M07 Psoriatic and enteropathic arthropathies
0.192 0.796 0.012
N23 Unspecified renal colic
0.201 0.799 0.000
E46 Unspecified protein-energy malnutrition
0.001 0.809 0.190
L41 Parapsoriasis
0.174 0.825 0.000
T40.4 Other synthetic narcotics
0.164 0.836 0.000
M06.4 Inflammatory polyarthropathy
0.001 0.836 0.163
L44 Other papulosquamous disorders
0.160 0.840 0.001
L45 Papulosquamous disorders in diseases classified elsewhere
0.160 0.840 0.001
E67.8 Other specified hyperalimentation
0.000 0.851 0.149
E67.3 Hypervitaminosis D
0.000 0.851 0.149
E67.2 Megavitamin-B6 syndrome
0.000 0.851 0.149
E67.1 Hypercarotenaemia
0.000 0.851 0.149
E67.0 Hypervitaminosis A
0.000 0.851 0.149
M06.8 Other specified rheumatoid arthritis
0.001 0.851 0.148
M06.2 Rheumatoid bursitis
0.001 0.851 0.148
M06.1 Adult-onset Still's disease
0.001 0.851 0.148
M07.6 Other enteropathic arthropathies
0.138 0.853 0.009
M07.5 Arthropathy in ulcerative colitis
0.138 0.853 0.009
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.138 0.853 0.009
M07.2 Psoriatic spondylitis
0.138 0.853 0.009
M07.1 Arthritis mutilans
0.138 0.853 0.009
M07.0 Distal interphalangeal psoriatic arthropathy
0.138 0.853 0.009
M06.3 Rheumatoid nodule
0.001 0.856 0.143
L41.1 Pityriasis lichenoides chronica
0.140 0.860 0.000
L42 Pityriasis rosea
0.139 0.861 0.001
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.863 0.137
E11 Non-insulin-dependent diabetes mellitus
0.000 0.874 0.125
L41.9 Parapsoriasis, unspecified
0.125 0.874 0.000
L41.8 Other parapsoriasis
0.125 0.874 0.000
L41.5 Retiform parapsoriasis
0.125 0.874 0.000
L41.4 Large plaque parapsoriasis
0.125 0.874 0.000
L41.3 Small plaque parapsoriasis
0.125 0.874 0.000
L41.2 Lymphomatoid papulosis
0.125 0.874 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.125 0.874 0.000
E65 Localised adiposity
0.001 0.877 0.123
E11.3 With ophthalmic complications
0.000 0.877 0.123
M06.0 Seronegative rheumatoid arthritis
0.001 0.880 0.119
M06.48 Inflammatory polyarthropathy (Other)
0.001 0.882 0.117
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.001 0.882 0.117
M06.46 Inflammatory polyarthropathy (Lower leg)
0.001 0.882 0.117
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.001 0.882 0.117
M06.44 Inflammatory polyarthropathy (Hand)
0.001 0.882 0.117
M06.43 Inflammatory polyarthropathy (Forearm)
0.001 0.882 0.117
M06.42 Inflammatory polyarthropathy (Upper arm)
0.001 0.882 0.117
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.001 0.882 0.117
H30-H36 Disorders of choroid and retina
0.000 0.882 0.117
L44.9 Papulosquamous disorder, unspecified
0.115 0.885 0.001
L44.8 Other specified papulosquamous disorders
0.115 0.885 0.001
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.115 0.885 0.001
L44.3 Lichen ruber moniliformis
0.115 0.885 0.001
L44.2 Lichen striatus
0.115 0.885 0.001
L44.1 Lichen nitidus
0.115 0.885 0.001
L44.0 Pityriasis rubra pilaris
0.115 0.885 0.001
M06.34 Rheumatoid nodule (Hand)
0.000 0.886 0.113
H31 Other disorders of choroid
0.000 0.889 0.111
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.001 0.890 0.110
M06.19 Adult-onset Still's disease (Site unspecified)
0.001 0.893 0.106
M06.18 Adult-onset Still's disease (Other)
0.001 0.893 0.106
M06.17 Adult-onset Still's disease (Ankle and foot)
0.001 0.893 0.106
M06.16 Adult-onset Still's disease (Lower leg)
0.001 0.893 0.106
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.001 0.893 0.106
M06.14 Adult-onset Still's disease (Hand)
0.001 0.893 0.106
M06.13 Adult-onset Still's disease (Forearm)
0.001 0.893 0.106
M06.12 Adult-onset Still's disease (Upper arm)
0.001 0.893 0.106
M06.11 Adult-onset Still's disease (Shoulder region)
0.001 0.893 0.106
M06.10 Adult-onset Still's disease (Multiple sites)
0.001 0.893 0.106
M06.29 Rheumatoid bursitis (Site unspecified)
0.001 0.893 0.106
M06.28 Rheumatoid bursitis (Other)
0.001 0.893 0.106
M06.27 Rheumatoid bursitis (Ankle and foot)
0.001 0.893 0.106
M06.26 Rheumatoid bursitis (Lower leg)
0.001 0.893 0.106
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.001 0.893 0.106
M06.24 Rheumatoid bursitis (Hand)
0.001 0.893 0.106
M06.23 Rheumatoid bursitis (Forearm)
0.001 0.893 0.106
M06.22 Rheumatoid bursitis (Upper arm)
0.001 0.893 0.106
M06.21 Rheumatoid bursitis (Shoulder region)
0.001 0.893 0.106
M06.20 Rheumatoid bursitis (Multiple sites)
0.001 0.893 0.106
M06.89 Other specified rheumatoid arthritis (Site unspecified)
0.001 0.893 0.106
M06.88 Other specified rheumatoid arthritis (Other)
0.001 0.893 0.106
M06.87 Other specified rheumatoid arthritis (Ankle and foot)
0.001 0.893 0.106
M06.86 Other specified rheumatoid arthritis (Lower leg)
0.001 0.893 0.106
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)
0.001 0.893 0.106
M06.84 Other specified rheumatoid arthritis (Hand)
0.001 0.893 0.106
M06.83 Other specified rheumatoid arthritis (Forearm)
0.001 0.893 0.106
M06.82 Other specified rheumatoid arthritis (Upper arm)
0.001 0.893 0.106
M06.81 Other specified rheumatoid arthritis (Shoulder region)
0.001 0.893 0.106
M06.80 Other specified rheumatoid arthritis (Multiple sites)
0.001 0.893 0.106
H31.8 Other specified disorders of choroid
0.000 0.894 0.106
N20-N23 Urolithiasis
0.106 0.894 0.000
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.099 0.895 0.006
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.099 0.895 0.006
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.099 0.895 0.006
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.099 0.895 0.006
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.099 0.895 0.006
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)
0.099 0.895 0.006
M07.03 Distal interphalangeal proriatic arthropathy-Forearm
0.099 0.895 0.006
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm
0.099 0.895 0.006
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region
0.099 0.895 0.006
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)
0.099 0.895 0.006
M07.19 Arthritis mutilans (Site unspecified)
0.099 0.895 0.006
M07.18 Arthritis mutilans (Other)
0.099 0.895 0.006
M07.17 Arthritis mutilans (Ankle and foot)
0.099 0.895 0.006
M07.16 Arthritis mutilans (Lower leg)
0.099 0.895 0.006
M07.15 Arthritis mutilans (Pelvic region and thigh)
0.099 0.895 0.006
M07.14 Arthritis mutilans (Hand)
0.099 0.895 0.006
M07.13 Arthritis mutilans (Forearm)
0.099 0.895 0.006
M07.12 Arthritis mutilans (Upper arm)
0.099 0.895 0.006
M07.11 Arthritis mutilans (Shoulder region)
0.099 0.895 0.006
M07.10 Arthritis mutilans (Multiple sites)
0.099 0.895 0.006
M07.29 Psoriatic spondylitis (Site unspecified)
0.099 0.895 0.006
M07.28 Psoriatic spondylitis (Other)
0.099 0.895 0.006
M07.27 Psoriatic spondylitis (Ankle and foot)
0.099 0.895 0.006
M07.26 Psoriatic spondylitis (Lower leg)
0.099 0.895 0.006
M07.25 Psoriatic spondylitis (Pelvic region and thigh)
0.099 0.895 0.006
M07.24 Psoriatic spondylitis (Hand)
0.099 0.895 0.006
M07.23 Psoriatic spondylitis (Forearm)
0.099 0.895 0.006
M07.22 Psoriatic spondylitis (Upper arm)
0.099 0.895 0.006
M07.21 Psoriatic spondylitis (Shoulder region)
0.099 0.895 0.006
M07.20 Psoriatic spondylitis (Multiple sites)
0.099 0.895 0.006
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)
0.099 0.895 0.006
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)
0.099 0.895 0.006
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)
0.099 0.895 0.006
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)
0.099 0.895 0.006
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)
0.099 0.895 0.006
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)
0.099 0.895 0.006
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)
0.099 0.895 0.006
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)
0.099 0.895 0.006
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)
0.099 0.895 0.006
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)
0.099 0.895 0.006
M07.59 Arthropathy in ulcerative colitis (Site unspecified)
0.099 0.895 0.006
M07.58 Arthropathy in ulcerative colitis (Other)
0.099 0.895 0.006

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.